BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3879053)

  • 21. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Summary of a new assessment strategy in positive occult blood tests in mass screening].
    Robra BP
    Leber Magen Darm; 1987 Apr; 17(2):113-24. PubMed ID: 3586827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
    Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
    Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [DNA test as colon cancer screening. Hemoccult and colonoscopy are actually more reliable].
    Freitag MH
    MMW Fortschr Med; 2005 Apr; 147(16):10. PubMed ID: 16392392
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemoccult test as a routine screening procedure for colorectal disease in the private clinic setting.
    Stewart HL; Wiens E
    Can J Surg; 1979 Nov; 22(6):572-4. PubMed ID: 497930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon polyps and cancer.
    Kronborg O
    Endoscopy; 2002 Jan; 34(1):69-72. PubMed ID: 11778132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemoccult tests of the stool at the time of preventive gynaecological examination (author's transl)].
    Reidel H; Heyer I; Schumann K; Helmstaedt D; Otto P
    Geburtshilfe Frauenheilkd; 1977 Jan; 37(1):27-35. PubMed ID: 836456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current challenges in cancer screening. Part I. Colon cancer screening.
    Shim K
    Dis Mon; 2000 Jun; 46(6):367-80. PubMed ID: 10909859
    [No Abstract]   [Full Text] [Related]  

  • 39. [The hemoccult test in the screening for colonic carcinoma].
    Deyhle P; Nüesch HJ; Kobler E; Jenny S; Säuberli H
    Schweiz Med Wochenschr; 1976 Feb; 106(9):297. PubMed ID: 1257722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical comparison of hemoFEC with Hemoccult II (author's transl)].
    Gnauck R
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1648-9. PubMed ID: 699787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.